Latest KFF Health News Stories
Different Takes: Lying Gets A Thumbs Up Instead Of Women’s Right To Abortion; Free Speech Wins
Opinion writers focus on the U.S. Supreme Court’s ruling to overturn a California law requiring pregnancy centers to inform patients about low-cost birth control and abortions.
Perspectives: The Government Should Utilize An Obscure Patent Provision To Lower Drug Prices
Read recent commentaries about drug-cost issues.
What Happens When A State’s Medicaid Program Decides A Drug Isn’t Worth The Cost?
News outlets report on stories related to pharmaceutical pricing.
Media outlets report on news from California, Minnesota, Wisconsin, Oklahoma, Tennessee, Texas, Kansas, Massachusetts and Virginia.
Much-Hyped Easy-To-Take Flu Drug Could Be Approved By FDA Before Next Season’s Peak
People are buzzing about the single-dose drug that could revolutionize the way the flu is treated. Not only is it easy to take, but it’s been shown to reduce the duration of flu symptoms by a little more than a day and reduce the duration of fever by nearly a day. In other public health news: contagious rudeness, osteoporosis, Zika, end-of-life care, and walking.
While the company has been hailed for its benefits for LBGTQ workers, this change is a big step forward that allows “them to truly be who they are,” said Ron Crawford, vice president of benefits at Starbucks. In other news, an Ohio proposal requires teachers to report potentially transgender children to their parents.
The state is just the latest to propose such legislation, which reflects ongoing concern among local governments that seek to reduce contaminants in drinking water and lower the threat of drug abuse stemming from drugs that linger in household medicine chests. In other news, China officials says U.S. should look at domestic factors before pointing the finger at them over the epidemic and the tech industry asserts its interest in playing a role in curbing the crisis.
While the government will match rates of around 90 percent for expansion enrollees, for those who were enrolled pre-expansion the rates are much lower. The crackdown is part of a larger plan to cut improper payments within Medicaid. Other news on the program comes out of Iowa and California.
Work At Ariadne Labs Reveals Glimpse Of Gawande’s Approach To Improving Health Care System
Stat examines the bold ideas and the real-world failures of Ariadne Labs, a partnership between a major Boston hospital and Harvard University, which Dr. Atul Gawande ran. His time there offers a look at what direction he’ll take as the new head of the Amazon, Berkshire Hathaway, and JPMorgan Chase health initiative.
Despite deep political divisions over what to do with the health law, there seems to be one thing that many people can agree with: people with pre-existing conditions should still be able to get coverage just like consumers without them. In other health law news: the senators involved in pushing the ACA to passage reflect on the years since it became law, and Notre Dame students sue over the administration’s rollback of contraception coverage.
HHS Secretary Alex Azar said there’s no reason that a parent wouldn’t know where their child is, and put the onus on Congress to come up with a solution for the crisis. “I cannot reunite them while the parents are in custody because of the court order that doesn’t allow the kids to be with their parents for more than 20 days. We need Congress to fix that,” Azar said. Meanwhile, more than a dozen states are suing the administration over its separation policy, and a federal judge rules that all families that have been separated must be reunited within 30 days.
VA Pick Has Long History Of Fighting On Front Lines Of His Bosses’ Culture Wars
President Donald Trump’s pick for VA secretary, Robert Wilkie, will have his hearing in front of the Senate today. He brings with him three decades of experience with military policies and a history of working with some polarizing politicians.
The California law at the center of the case required clinics that counsel women against abortion to inform clients of the availability of abortions paid for by the state. The justices ruled that the measure violates the First Amendment. Justice Clarence Thomas wrote that California can use other means to tell women about the availability of the procedure, but it “cannot co-opt the licensed facilities to deliver its message for it.”
Polio Virus Boosts Survival Rates For Patients With Viciously Lethal Brain Tumor
Even with aggressive treatment, people diagnosed with Glioblastoma typically survive less than 20 months, while those with a recurrence usually die within a year. But 21 percent of the patients treated with the polio virus — all with disease that had recurred — were alive after three years. Scientists caution the treatment is in the very early stages.
Today’s early morning highlights from the major news organizations.
Opinion pages focus on these and other health issues.
Media outlets report on news from Michigan, Mississippi, Texas, California, Massachusetts and Pennsylvania.
Amerigroup To Fight Kansas’ Decision To Drop Insurer From KanCare Contracts
The Kansas Department of Health and Environment announced that it will replace Amerigroup with Aetna. A spokeswoman for the company said Amerigroup has provided Kansans on Medicaid “improved access to high-quality health care since 2013” and today serves more than 127,000 KanCare recipients. Medicaid news comes out of Florida and Ohio, as well.
High Suicide Rates, Opioid Epidemic At Top Of New CDC Director’s Priorities
Robert Redfield, in his first interview in the position of CDC director, talked about the importance of realizing the role firearms play in the country’s suicide rate as well as his personal connection to the opioid crisis. In other public health news: the “marshmallow test,” DNA collection, dementia and guns, meditation, palliative care and more.
Woman Claims Pharmacist Refused To Fill Her Miscarriage Drug On Moral Grounds
The Arizona State Board of Pharmacy is investigating the allegations. Meanwhile, the scandal at USC has lead to a moment of reckoning and reflection in the gynecology field.
